| Literature DB >> 17360108 |
Guiqin Hou1, Lexun Xue, Zhaoming Lu, Tianli Fan, Fang Tian, Yanli Xue.
Abstract
mTOR/p70S6K pathway is considered a central regulator in various malignant tumors, but its roles in esophageal squamous cell carcinoma (ESCC), which is a common cause of mortality in China, remain unknown. Here, we identify that the mTOR/p70S6K pathway is activated in ESCC; rapamycin and siRNA against mTOR rapidly inhibited expression of mTOR and the phosphorylation of its major downstream effectors, p70S6K and 4E-BP1, arrested cells in the G(0)/G(1) phase and induced apoptosis of ESCC cells. The findings may lay a foundation for making further investigations on the mTOR/p70S6K pathway as a potential target for ESCC therapy.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17360108 DOI: 10.1016/j.canlet.2007.01.026
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679